Peak oxygen uptake, muscle volume, and the growth hormone-insulin-like growth factor-I axis in adolescent males

Medicine and Science in Sports and Exercise

Volumn 30, Issue 4, 1998, Pages 512-517

  Eliakim, Alon ^b   Brasel, Jo Anne ^b   Barstow, Thomas J ^b   Mohan, Subburaman ^b   Cooper, Dan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Binding proteins; Exercise; Muscle mass; Peak oxygen uptake

Indexed keywords

BINDING PROTEIN; GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; BICYCLE ERGOMETRY; BODY GROWTH; CLINICAL ARTICLE; EXERCISE; FEMALE; HUMAN; HYPOPHYSIS FUNCTION; LIGAND BINDING; MALE; MUSCLE MASS; NEUROENDOCRINE SYSTEM; OXYGEN CONSUMPTION; PEAK EXPIRATORY FLOW; PUBERTY; PULSATILE FLOW; VITAL CAPACITY;

ADOLESCENT; CARRIER PROTEINS; EXERCISE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PHYSICAL FITNESS;

EID: 0031899703     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005768-199804000-00007     Document Type: Article

References (41)

1. ADAMO, M. L., M. A. BACH, C. T. ROBERTS, and D. LEROITH. Regulation of insulin, IGF-1, and IGF-2 g, and IGF-2 gene expression. In: Insulin-like Growth Factors: Molecular and Cellular Aspects D. LeRoith (Ed.). Boca Raton: CRC Press, 1991, pp. 271-303.
2. BEAVER, W. L., N. LAMARRA, and K. WASSERMAN. Breath-by-breath measurement of true alveolar gas exchange. J. Appl. Physiol. 51:1662-1675, 1981.
3. BORER, K. T., D. R. NICOSKI, and V. OWENS. Alteration of pulsatile growth hormone secretion by growth- inducing exercise: involvement of endogenous opiates and somatostatin. Endocrinology 118:844-850, 1986.
4. CARLSSON, L. M., A. M. ROWLAND, R. G. CLARK, N. GESUNDHEIT, and W. L. WONG. Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood. J. Clin, Endocrinol. Metab. 73:1216-1223, 1991.
5. COOPER, D. M. Development of the oxygen transport system in normal children. In: Advances in Pediatric Sport Sciences: Volume 3-Biological Issues, O. Bar-Or (Ed.). Champaign, IL: Human Kinetics Books, 1989, pp. 67-100.
6. COOPER, D. M., D. WEILER-RAVELL, B. J. WHIPP, and K. WASSERMAN. Aerobic parameters of exercise as a function of body size during growth in children. J. Appl. Physiol. 56:628-634, 1984.
7. DAUGHADAY, W. H., M. KAPADIA, and I. MARIZ. Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay. J. Lab Clin. Med. 109:355-363, 1987.
8. DEVOL, D. L., P. ROTWEIN, J. L. SADOW, J. NOVAKOFSKI, and P. J. BECHTEL. Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth. Am. J. Physiol. 259:E89-E951990.
9. DONNELLY, M. J. and J. M. HOLLY. The role of IGFBP-3 in the regulation of IGFBP-4 proteolysis. J. Endocrinol. 149:R1-R7, 1996.
10. ELIAKIM, A., T. J. BARSTOW, J. A. BRASEL, et al. The effect of exercise training on energy expenditure, muscle volume, and maximal oxygen uptake in adolescent females. J. Pediatr. 129:537-543, 1996.
11. ELIAKIM, A., J. A. BRASEL, S. MOHAN, T. J. BARSTOW, N. BERMAN, and D. M. COOPER. Physical fitness, endurance training, and the GH-IGF-I system in adolescent females. J. Clin. Endocrinol. Metab. 81:3986-3992, 1996.
12. ELIAKIM, A., L. G. RAISZ, J. A. BRASEL, and D. M. COOPER. Evidence for increased bone formation following a brief endurance-type training intervention in adolescent males. J. Bone Mineral Res. 12:1708-13, 1997.
13. HAYDHN, J. M., S. MOHAN, and D. J. BAYLINK. The insulin-like growth factor system and the coupling of formation to resorption. Bone 17:93s-98s, 1995.
14. IP, T.-P., D. M. HUFFMAN, A. J. O'SULLIVAN, K.-C. LEUNG, and K. K. Y. Ho. Do androgen regulate growth hormone binding protein in adult men? J. Clin. Endocrinol. Metab. 80:1278-1282, 1995.
15. JOSPE, N., C. C. ORLOWSKI, and R. W. FURLANETTO. Comparison of transdermal and oral estrogen therapy in girls with Turner syndrome. J. Pediatr. Endocrinol. Metab. 8:111-116, 1995.
16. KELLEY, P. J., J. A. EISMAN, M. C. STUART, N. A. POCOCK, P. N. SAMBROOK. and T. H. GWINN. Somatomedin-c, physical fitness, and bone density. J. Clin. Endocrinol. Metab. 70:718-723, 1990.
17. KILLEN, J. D., C. B. TAYLOR, L. D. HAMMER, et al. An attempt to modify unhealthful eating attitudes and weight regulation practices of young adolescent girls. Int. J. Eat. Disord. 13:369-384, 1993.
18. LEROITH, D., M. ADAMO, H. WERNER, and C. T. ROBERTS, JR. Insulin-like growth factors and their receptors as growth regulators in normal physiology and pathologic states. Trends Endocrinol. Metab. 2:134-139, 1991.
19. LOWE, W. L., JR. Biological actions of the insulin-like growth factors. In: Insulin-Like Growth Factors: Molecular and Cellular Aspects, D. LeRoith (Ed.). Boca Raton: CRC Press, 1991, pp. 49-86.
20. MCDERMOTT, M. T. and E. C. RIDGWAY. Thyroid hormone resistance syndromes. Am. J. Med. 94:424-432, 1993.
21. MERIMEE, T. J. and Z. LARON. Growth hormone binding proteins of serum. In: Growth Hormone, IGF-I, and Growth; New Views of Old Concepts, T. J. Merimee and Z. Laron (Eds.). London: Freund Publishing House Ltd., 1996, pp. 11-22.
22. MOHAN, S., C. BAUTISTA, J. E. WERGEDAL, and D. J. BAYLINK. Isolation of a novel inhibitory IGF binding protein, a potential local regulator of IGF action in bone cell conditioned medium. Proc. Natl. Acad. Sci. 86:8338-8342, 1989.
23. MOHAN, S., C. LIBANATI, C. DONY, K. LANG, N. SRINIVASAN, and D. J. BAYLINK. Development, validation, and application of a rudioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J. Clin. Endocrinol. Metab. 80:2638-2645, 1995.
24. MOHAN, S., Y. NAKAO, Y. HONDA, et al. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J. Biol. Chem. 270:20424-20431, 1995.
25. MOHNIKE, K., U. KLUBA, W. F. BLUM, V. AUMANN, P. VORWERK, and U. MITTLER. Serum concentrations of insulin-like growth factors (IGF)-I and IGF-II and IGF binding proteins (IGFBP)-2 and IGFBP-3 in 49 children with ALL, NHL or solid tumors. Klin. Padiatr. 207:225-229, 1995.
26. NOLL, K., B. R. WEGMANN, K. HAVEMANN, and G. JAQUES. Insulin like growth factors stimulate the release of insulin like binding protein-3 and degradation of IGFBP-4 in non small cell lung cancer cell lines. J. Clin. Endocrinol. Metab. 81:2653-2662, 1996.
27. OLIVIE, M. A. A., R. V. GARCIA-MAYOR, D. G. LESION, et al. Serum insulin-like growth factor binding protein-3 and IGF-I levels during childhood and adolescence: a cross-sectional study. Pediatr. Res. 38:149-155, 1995.
28. PARKKOLA, R., U. KUJALA, and U. RYTOKOSKI. Response of the trunk muscles to training assessed by magnetic resonance imaging and muscle strength. Eur. J. Appl. Physiol. 65:383-387, 1992.
29. POEHLMAN, E. T. and K. C. COPELAND. Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. J. Clin. Endocrinol. Metab. 71:1468-1473, 1990.
30. PONTIROLI, A. E., R. LANZI, L. D. MONTI, E. SANDOLI, and G. POZZA. Growth hormone (GH) autofeedback on GH response to GH-releasing hormone: role of free fatty acids and somatostatin. J. Clin. Endocrinol. Metab. 72:492-495, 1991.
31. RAJKOVIC, I. A., E. VALIONTIS, and K. K. Ho. Direct quantitation of growth hormone binding protein in human serum by ligand-immunofunctional assay: comparison with immunoprecipitation and Chromatographic methods. J. Clin. Endocrinol. Metab. 78:772-777, 1994.
32. RECHLER, M. M. Insulin-like growth factor binding proteins. Vitam. Harm. 47:1-114, 1993.
33. ROMAN, W. J., J. FLECKENSTEIN, J. STRAY-GUNDERSEN, S. E. ALWAY, R. PESHOCK, and W. J. GONYEA. Adaptations in the elbow flexors of elderly males after heavy-resistance training. J. Appl. Physiol. 74:750-754, 1993.
34. ROSENFELD, R. G., G. LAMSON, H. PHAM, et al. Insulin-like growth factor binding proteins. Recent Prog. Horm. Res. 46:99-163, 1990.
35. SMITH, W. J., L. E. UNDERWOOD, and D. R. CLEMMONS. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J. Clin. Endocrinol. Metab. 80:443-449, 1995.
36. STRASBURGER, C., G. BARNARD, L. TOLDO, et al. Somatotropin as measured by a two-site time resolved immunofluorometric assay. Clin. Chem. 35:913-917, 1989.
37. TONSHOFF, B., W. F. BLUM, A. M. WINGEN, and O. MEHLS. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 i, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J. Clin. Endocrinol. Metab. 80:2684-2691, 1995.
38. VELDHUIS, J. D., A. IRANMANESH, K. K. Ho, M. J. WATERS, M. L. JOHNSON, and G. LIZARRALDE. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J. Clin. Endocrinol. Metab. 72:51-59, 1991.
39. WELTMAN, A., J. Y. WELTMAN, M. L. HARTMAN, Relationship beween age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender. J. Clin. Endocrinol. Metab. 78:543-548, 1994.
40. ZANCONATO, S., D. Y. MOROMISATO, M. Y. MOROMISATO, et al. Effect of training and growth hormone suppression on insulin-like growth factor-I mRNA in young rats. J. Appl. Physiol. 76:2204-2209, 1994.
41. ZANCONATO, S., G. REIDY, and D. M. COOPER. Calf muscle cross sectional area and maximal oxygen uptake in children and adults. Am. J. Physiol. 267:R720-R725, 1994.